Access cutting-edge kidney disease treatment through this clinical trial at a research site in Denver. Study-provided care at no cost to qualified participants.
Access kidney disease specialists in Denver at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney disease treatment provided free
This is an adaptive prospective, multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of WAL0921 in subjects with glomerular kidney disease and proteinuria, including diabetic nephropathy and rare glomerular kidney diseases (primary focal segmental glomerulosclerosis \[FSGS\], treatment-resistant minimal change disease \[TR MCD\], primary immunoglobulin A nephropathy \[IgAN\], and primary membranous nephropathy
Sponsor: Walden Biosciences
Check if you qualify for this kidney disease clinical trial in Denver, CO
If you're searching for kidney disease treatment options in Denver, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Denver research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.